The major stress-inducible heat shock protein 70 (Hsp70) 
Introduction
Our search for innovative tumour-specific target structures for tumour therapy revealed heat shock protein 70 (Hsp70-1, HspA1A #3303) [1] , the major stress-inducible member of the 70 kD heat shock proteins, as one such target. Both, Hsp70 and gp96, an endoplasmic reticulum resident member of the 90 kD heat shock protein group (gp96, HspC3 #7184), have been found on the plasma membrane of a variety of different human tumours [2] [3] [4] . During these studies we generated and characterized a mouse monoclonal antibody (mAb), termed cmHsp70.1, which specifically detects the cell surface localized Hsp70 on viable tumour cells with intact plasma membrane. The amino acid sequence of the Hsp70 molecule, which is exposed to the extracellular milieu of these tumours has been identified as being part of the 14-mer peptide TKDNNLLGRFELSG (TKD) [5, 6] .
Screening of tumour biopsies and the corresponding normal tissues has indicated that primary diagnosed carcinoma samples, but none of the tested normal tissues, frequently exhibit an Hsp70
membrane-positive phenotype [7] [8] [9] . Moreover, an Hsp70 membrane-positive tumour phenotype has been associated with a significantly decreased overall survival in patients with lung cancer and lower rectal carcinomas suggesting that Hsp70 membranepositivity might serve as a negative prognostic marker [10] . It has also been shown that the density of membrane Hsp70 on tumour cells can be further enhanced following therapeutic intervention such as radiotherapy or chemotherapy [11] .
The anchorage of Hsp70 protein in the plasma membrane of non-stressed tumours is enabled by the glycosphingolipid globoyltriaoslyceramide (Gb3) [12, 13] , which is frequently overexpressed in colorectal and gastric tumours and rarely found in the plasma membrane of normal cells. Following stress, elevated levels of Hsp70 are co-located with phosphatidylserine on the cell surface of tumour cells [14] [15] [16] . Moreover, an Hsp70 membrane-positive phenotype is associated with a higher resistance towards radiochemotherapy and membrane Hsp70 expression might therefore predict an unfavourable therapeutic outcome in lung and lower rectal tumours [17] . [18] . 
Taken together, these findings indicate the importance of determining the Hsp70 membrane status of tumours. Within the last few years, non-invasive devices for the imaging of tumours in small animals have been developed
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Materials and methods
Mouse tumour cell lines
The tumorigenic CT26 mouse colon adenocarcinoma (CT26.WT; ADCC CRL-2638) [19] 
Flat-panel volume CT (VCT)
A flat-panel VCT (Fig. 4A) (Fig. 1C, upper right panel) . In contrast, at 4ЊC the proportion of Hsp70 membrane-positive tumour cells remained nearly unchanged up to 60 min. (Fig. 1C,  upper left panel) . Furthermore, the mean fluorescence intensity (mfi) of Hsp70 per cell significantly increased after incubation with antibody at 37ЊC from 2 to 60 min. (Fig. 1C, lower right panel) , but remained stably low at 4ЊC (Fig. 1C, lower left 
cells at 4ЊC (left panel) and 37ЊC (right panel). The upper graphs indicate the percentage of positively stained cells the lower graphs indicate the antigen densities at the indicated time-points, expressed as the mfi. The increase in the proportion of membrane Hsp70 ϩ cells and in the mfi was significant (P Ͻ 0.05) at 37ЊC but not at 4ЊC. (D) Representative immunofluorescence images of CT26 tumour cells either stained with cmHsp70.1-FITC (green, first row) or with Cy3-secondary antibody labelled (red, second row) Rab4 (early endosome), Rab5a (early endosome), Rab7 (late endosome), Rab9 (late endosome), Rab11 (trans golgi network, recycling endosome), LAMP1 (CD107, lysosome), LAMP2 (lysosome) antibodies at 4ЊC (left three rows) and after an incubation of 30 min. at 37ЊC (right three rows). A co-localization of the FITC (green) and Cy3 (red) fluorescence, as indicated in a yellow spectrum (third row), is marked with 'ϩ' in the merged fluorescence staining pattern. Isotype-matched control antibodies did not show any staining (data not shown). Similar results were obtained in three independent experiments. The scale bar represents 20 m.
tumours (Fig. 3, black bars) (Fig. 4D, left panel) and normal tissues (lung; Fig. 4D, right panel) of the identical animals. An endo-lysosomal Cy5.5 staining pattern, as already shown for in vitro cultured CT26 tumour cells (Fig. 1D) , is detectable only in the tumour sections by using the cmHsp70.1 mAb, but not in normal tissues (Fig. 4D, lower panel) . The IgG1 control antibody did neither stain tumour nor normal tissues including liver, lung and heart. The lung is shown as a representative example for the normal tissue in the upper panel of Figure 4D . Fig. 5A ) and normal tissues, such as the liver (Fig. 5B) , lung ( Fig. 5C ) and kidney (Fig. 5D) (Fig. 6B, right panel) . A quantitative analysis of the average fluorescence intensities in these two mice at the indicated time-points is summarized in Figure 6C . It appears that the average intensity of the cmHsp70. 1 (Fig. 6D) .
Effects of cmHsp70.1 mAb on CT26 tumour cells in vitro
Although it is known that IgG1 mouse monoclonal antibodies in general have a low capacity to mediate ADCC, the cmHsp70.1 mAb was tested against Hsp70 membrane-positive CT26 tumour cells. [10] , and thus might act as a negative prognostic marker. In contrast, patients whose tumours metastasize into the 
